KO
47
-3
CRM
49
4
SYY
52
2
NWSA
80
-4
NEE
54
2
VRSK
35
-3
SYF
74
-2
WFC
74
3
MOS
53
4
BIIB
43
-2
QCOM
57
2
FIS
53
-2
UHS
42
-2
MTCH
68
15
PNC
61
2
RF
66
8
NDAQ
67
-3
MNST
42
-2
AVGO
40
-2
MU
44
2
KO
47
-3
CRM
49
4
SYY
52
2
NWSA
80
-4
NEE
54
2
VRSK
35
-3
SYF
74
-2
WFC
74
3
MOS
53
4
BIIB
43
-2
QCOM
57
2
FIS
53
-2
UHS
42
-2
MTCH
68
15
PNC
61
2
RF
66
8
NDAQ
67
-3
MNST
42
-2
AVGO
40
-2
MU
44
2
Financhill
Back

NYLI MacKay Muni Intermediate ETF Vs. Cidara Therapeutics Industry Stock Comparison

Sell
23

MMIT
NYLI MacKay Muni Intermediate ETF

Last Price:
$23.72
Seasonality Move:
-1.08%
Buy
74

CDTX
Cidara Therapeutics

Last Price:
$57.03
Seasonality Move:
-8.92%
Sell
23
NYLI MacKay Muni Intermediate ETF (MMIT) is a Sell

Is NYLI MacKay Muni Intermediate ETF a Buy, Sell or Hold?

  • The current NYLI MacKay Muni Intermediate ETF [MMIT] share price is $23.70. The Score for MMIT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • MMIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $59.96. The Score for CDTX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MMIT Stock Price Chart

What is NYLI MacKay Muni Intermediate ETF's stock price today?

  • The NYLI MacKay Muni Intermediate ETF share price today is $23.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMIT is experiencing slight selling pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $59.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MMIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.59 Buy
Relative Strength Index (14 RSI): 41.59 Sell
Chaikin Money Flow: -106193 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.74 - 23.82) Sell
Bollinger Bands (100): (23.63 - 24.05) Sell

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.78 Buy
Relative Strength Index (14 RSI): 78.27 Buy
Chaikin Money Flow: 597837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.33 - 56.13) Buy
Bollinger Bands (100): (15.72 - 38.82) Buy

MMIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.74 Sell
20-day SMA: 23.78 Sell
50-day SMA: 23.76 Sell
200-day SMA: 24.04 Sell
8-day EMA: 21.26 Buy
20-day EMA: 14.09 Buy
50-day EMA: 7.18 Buy
200-day EMA: 2.04 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.45 Buy
20-day SMA: 49.02 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.73 Buy
8-day EMA: 53.91 Buy
20-day EMA: 47.78 Buy
50-day EMA: 37.74 Buy
200-day EMA: 25.19 Buy

NYLI MacKay Muni Intermediate ETF Earnings Growth & MMIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.

NYLI MacKay Muni Intermediate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):